CLINICAL_TRIALS
research
· 2025-09-09
Clinical Trial Update: Combination Immunotherapy Targeting Melanoma [Phase 1, Phase 2]
Summary
A phase 1/2 clinical trial of a combination immunotherapy for melanoma is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Melanoma | Phase 1, Phase 2 | Status: RECRUITING